ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $23,340,000 | +39.1% | 135,593 | +1.4% | 0.01% | +60.0% |
| Q2 2021 | $16,774,000 | -1.3% | 133,679 | +6.6% | 0.01% | -16.7% |
| Q1 2021 | $16,998,000 | +30.1% | 125,368 | +22.8% | 0.01% | +20.0% |
| Q4 2020 | $13,067,000 | +17.2% | 102,131 | +3.1% | 0.01% | 0.0% |
| Q3 2020 | $11,150,000 | -35.2% | 99,081 | -45.1% | 0.01% | -37.5% |
| Q2 2020 | $17,204,000 | +18.5% | 180,565 | +11.7% | 0.01% | 0.0% |
| Q1 2020 | $14,524,000 | +125.3% | 161,723 | +33.0% | 0.01% | +300.0% |
| Q4 2019 | $6,446,000 | +56.3% | 121,584 | +16.5% | 0.00% | 0.0% |
| Q3 2019 | $4,124,000 | +138.9% | 104,335 | +148.3% | 0.00% | +100.0% |
| Q2 2019 | $1,726,000 | – | 42,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |